Decaprenylphospho-beta-D-ribofuranose 2-oxidase

Decaprenylphospho-beta-D-ribofuranose 2-oxidase
Identifiers
EC no.1.1.98.3
Databases
BRENDAenzyme data
ExPASyNiceZyme view
KEGGenzyme entry
MetaCycmetabolic pathway
Rheareactions
PDB structuresRCSB PDB PDBe PDBsum
Search
PMCarticles
PubMedarticles
NCBIproteins

Decaprenylphospho-beta-D-ribofuranose 2-oxidase (EC 1.1.98.3, decaprenylphosphoryl-beta-D-ribofuranose 2'-epimerase, Rv3790, DprE1) is an enzyme with systematic name trans,octacis-decaprenylphospho-beta-D-ribofuranose:FAD 2-oxidoreductase.[1][2] This enzyme catalyses the following chemical reaction

trans,octacis-decaprenylphospho-beta-D-ribofuranose + FAD trans,octacis-decaprenylphospho-beta-D-erythro-pentofuranosid-2-ulose + FADH2

This enzyme from the bacterium Mycobacterium smegmatis participates in epimerization of trans,octacis-decaprenylphospho-beta-D-ribofuranose to trans,octacis-decaprenylphospho-beta-D-arabinoofuranose.

Macozinone and quabodepistat are two investigational drugs that target DprE1.[3]

References

  1. ↑ Ribeiro AL, Degiacomi G, Ewann F, Buroni S, Incandela ML, Chiarelli LR, et al. (2011). "Analogous mechanisms of resistance to benzothiazinones and dinitrobenzamides in Mycobacterium smegmatis". PLOS ONE. 6 (11) e26675. Bibcode:2011PLoSO...626675D. doi:10.1371/journal.pone.0026675. PMC 3206020. PMID 22069462.
  2. ↑ Trefzer C, Škovierová H, Buroni S, Bobovská A, Nenci S, Molteni E, et al. (January 2012). "Benzothiazinones are suicide inhibitors of mycobacterial decaprenylphosphoryl-β-D-ribofuranose 2'-oxidase DprE1". Journal of the American Chemical Society. 134 (2): 912–915. doi:10.1021/ja211042r. PMID 22188377.
  3. ↑ Jaorawala Z, Samaiya PK, Parida KK, Kalia NP, Tanwar O (January 2026). "Preclinical and Clinical Efficacy of Promising DprE1 Inhibitors: A Critical Review". ChemistrySelect. 11 (1). doi:10.1002/slct.202505382.